A STUDY ON THE HUMAN RIGHTS IMPLICATIONS OF INDIA’S SURROGACY (REGULATION) ACT, 2021
Indian Journal of Legal Review · 2023
DOI: 10.65393/cpiv2403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Legal Review, 2023. Verfasst von VARSHA D. VYAS und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
The Surrogacy (Regulation) Act, 2021 represents a major shift in India’s legal framework governing assisted reproductive technologies. Enacted to curb unethical practices and protect surrogate mothers from exploitation, the Act bans commercial surrogacy and permits only altruistic surrogacy under strict eligibility conditions. While the law aims to safeguard dignity, equality, and bodily autonomy, it has also raised substantial human rights concerns—especially with respect to reproductive autonomy, right to parenthood, equality for LGBTQ+ individuals, single persons, and foreign nationals. This paper critically examines the human rights implications of the 2021 Act as relevant up to the year 2022, analysing its strengths, limitations, and impact on vulnerable groups. It concludes with recommendations for balancing ethical safeguards with reproductive choice and non-discrimination. Keywords: Surrogacy, Human Rights, Bodily Autonomy, Reproductive Rights, Commercial Surrogacy, Surrogacy (Regulation) Act 2021, Equality, Parenthood Rights.
Zitieren
APA
VYAS, V. D., KAUR, A. P., & GULATI, S. (2023). A STUDY ON THE HUMAN RIGHTS IMPLICATIONS OF INDIA’S SURROGACY (REGULATION) ACT, 2021. Indian Journal of Legal Review. https://doi.org/10.65393/cpiv2403
Vancouver
VYAS VD, KAUR AP, GULATI S. A STUDY ON THE HUMAN RIGHTS IMPLICATIONS OF INDIA’S SURROGACY (REGULATION) ACT, 2021. Indian Journal of Legal Review. 2023. doi:10.65393/cpiv2403
BibTeX
@article{VYAS2023,
author = {VYAS, VARSHA D. and KAUR, ARSHI PAL and GULATI, SHOBHA},
title = {A STUDY ON THE HUMAN RIGHTS IMPLICATIONS OF INDIA’S SURROGACY (REGULATION) ACT, 2021},
journal = {Indian Journal of Legal Review},
year = {2023},
doi = {10.65393/cpiv2403}
}
EUVIMED